Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 1998

View Archived Issues

InSite Vision highlights recent accomplishments in shareholder update

Pharmacia & Upjohn launches new antidepressant in Germany

Oxford GlycoSciences: six-month highlights

Herbal mixture used for prostate cancer found to have potent estrogenic effects

Siga will collaborate with Ludwig Institute to develop cancer vaccines

New technology useful for identifying protein targets for anti-H. pylori agents

Novel Lp(a)-lowering agents prepared by SKB-Symphar team

Modulators of neurotransmitter function claimed by Hoechst Marion Roussel for depression, PD

Heterocyclic anticoagulants in development at BioChem Pharma

Knoll claims another series of heteroarylsulfonamide compounds for CNS and other disorders

Japanese laboratory synthesizes new antidiabetic agents

Israeli investigators disclose novel series of neuroprotective compounds

Sepracor initiates clinical testing with Prozac isomer

Chinese herbal extract prevents stress and fatigue in preclinical models

Collaborative agreements in the field of asthma signed by SkyePharma and Sepracor

3M launches revolutionary new treatment for external genital and perianal warts in U.K.

BioNumerik publishes preclinical data on BNP-7787 in cancer journal

U.K. launch announced for Evista

Pharming and Genzyme form joint venture to develop enzyme for Pompe's disease

International research team elucidates role of ubiquitin pathway in Parkinson's disease

Phase I trials to begin with vomeropherin compound for PMS

Update on development of ViroPharma's pleconaril

United Therapeutics reports successful completion of pilot study in PVD

New compound reported in clinical development at Lilly

NeXstar reorganizes into two separate companies

United Biomedical's B4 antibody holds promise for postexposure prophylaxis of HIV infection

Ampakine compounds receive further patent protection; update on progress of second-generation drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...